Table 2

Effects for treatment on depressive symptomatology severity, remission and relapse rates

kNEffect sizeP value95% PII2 (95% CI)
Hedges’ g (95% CI)OR (95% CI)
Depressive symptomatology 710240.50 (0.23 to 0.76)0.004−0.06 to 1.0551.1 (0 to 79.2)
 Rater
  Clinician-rated44200.37 (−0.04 to 0.77)0.064−0.55 to 1.2838.4 (0 to 79.0)
  Self-reported710240.48 (0.23 to 0.73)0.0040.02 to 0.9445.5 (0 to 77.0)
 Follow-up
  1–12 months37020.36 (−0.30 to 1.02)0.145−3.00 to 3.7266.9 (0 to 90.5)
  ≥12 months37020.02 (−0.09 to 0.12)0.579−0.94 to 0.980 (0 to 89.6)
Remission rates
 Post-treatment58042.57 (1.71 to 3.87)0.0031.56 to 4.220 (0 to 79.2)
 ≥6 months follow-up37021.75 (1.21 to 2.53)0.0230.25 to 12.420 (0 to 89.6)
Relapse rates
 Post-treatment32840.17 (0.01 to 4.83)0.150*62.7 (0 to 89.3)
 ≥6 months follow-up37020.46 (0.21 to 1.03)0.0530.04 to 5.350 (0 to 89.6)
  • *PI is not reported for this outcome, as the estimate is too broad to be useful given the limited number of studies and considerable heterogeneity.

  • PI, prediction interval.